Literature DB >> 33184193

Enhancing host cell infection by SARS-CoV-2.

Margaret Kielian1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33184193     DOI： 10.1126/science.abf0732

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  21 in total

Review 1.  Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target.

Authors:  Endeshaw Chekol Abebe; Teklie Mengie Ayele; Zelalem Tilahun Muche; Tadesse Asmamaw Dejenie
Journal:  Biologics       Date:  2021-05-06

Review 2.  Neuropilins: C-end rule peptides and their association with nociception and COVID-19.

Authors:  Amie Jobe; Ranjit Vijayan
Journal:  Comput Struct Biotechnol J       Date:  2021-03-26       Impact factor: 7.271

3.  Vascular Normalization to Improve Treatment of COVID-19: Lessons from Treatment of Cancer.

Authors:  Lance L Munn; Triantafyllos Stylianopoulos; Natalie K Jain; C Corey Hardin; Melin J Khandekar; Rakesh K Jain
Journal:  Clin Cancer Res       Date:  2021-03-01       Impact factor: 13.801

Review 4.  A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.

Authors:  Abdulaziz Alamri; Derek Fisk; Deepak Upreti; Sam K P Kung
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

Review 5.  COVID-19 and Dentistry in 72 Questions: An Overview of the Literature.

Authors:  Stéphane Derruau; Jérôme Bouchet; Ali Nassif; Alexandre Baudet; Kazutoyo Yasukawa; Sandrine Lorimier; Isabelle Prêcheur; Agnès Bloch-Zupan; Bernard Pellat; Hélène Chardin; Sophie Jung
Journal:  J Clin Med       Date:  2021-02-16       Impact factor: 4.241

Review 6.  COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.

Authors:  Larissa E van Eijk; Mathijs Binkhorst; Arno R Bourgonje; Annette K Offringa; Douwe J Mulder; Eelke M Bos; Nikola Kolundzic; Amaal E Abdulle; Peter Hj van der Voort; Marcel Gm Olde Rikkert; Johannes G van der Hoeven; Wilfred Fa den Dunnen; Jan-Luuk Hillebrands; Harry van Goor
Journal:  J Pathol       Date:  2021-03-25       Impact factor: 9.883

Review 7.  Hypertension, a Moving Target in COVID-19: Current Views and Perspectives.

Authors:  Carmine Savoia; Massimo Volpe; Reinhold Kreutz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

Review 8.  SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.

Authors:  Olivia Swain; Sofia K Romano; Ritika Miryala; Jocelyn Tsai; Vinnie Parikh; George K E Umanah
Journal:  J Neurosci       Date:  2021-06-23       Impact factor: 6.167

9.  Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists.

Authors:  Methus Klaewkla; Thanapon Charoenwongpaiboon; Panupong Mahalapbutr
Journal:  J Mol Liq       Date:  2021-05-20       Impact factor: 6.165

Review 10.  The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity?

Authors:  Annamaria Vianello; Serena Del Turco; Serena Babboni; Beatrice Silvestrini; Rosetta Ragusa; Chiara Caselli; Luca Melani; Luca Fanucci; Giuseppina Basta
Journal:  Biomedicines       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.